Drug Class Review on Pharmacologic Treatments for ADHD - OHSU
Drug Class Review on
Pharmacologic Treatments for ADHD
Final Report
EVIDENCE TABLES
May 2006
The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within
pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse
any guideline or recommendation developed by users of these reports.
Marian S. McDonagh, PharmD Kim Peterson, MS Oregon Evidence-based Practice Center Oregon Health & Science University Mark Helfand, MD, MPH, Director
Copyright ? 2006 by Oregon Health & Science University Portland, Oregon 97201. All rights reserved.
Final Report Update 1
Drug Effectiveness Review Project
TABLE OF CONTENTS
Evidence Tables Evidence Table 1. Placebo-controlled trials in preschool children and adolescents ...........3 Evidence Table 2. Quality of placebo-controlled trials in preschool children and adolescents. .........................................................................................57 Evidence Table 3. Head to Head trials in children with ADHD........................................66 Evidence Table 4. Quality assessment of head to head trials in children with ADHD ...318 Evidence Table 5. Placebo-controlled trials in children ..................................................354 Evidence Table 6. Quality of placebo-controlled trials in children .................................529 Evidence Table 7. Long-term efficacy trials....................................................................550 Evidence Table 8. Quality in long-term efficacy trials....................................................574 Evidence Table 9. Head to Head trials in adults with ADHD .........................................580 Evidence Table 10. Quality assessment of head to head trials in adults with ADHD.....604 Evidence Table 11. Placebo-controlled trials in adults with ADHD ...............................608 Evidence Table 12. Quality assessment of placebo-controlled trials in adults with ADHD.............................................................................................680 Evidence Table 13. Observational Studies - Functional Outcomes.................................696 Evidence Table 14. Quality assessment of observational studies - Functional Outcomes............................................................................711 Evidence Table 15. Observational studies - Long term safety ........................................717 Evidence Table 16. Quality of observational studies of long-term safety.......................792
Suggested Citation:
McDonagh MS, Peterson K. Drug Class Review on Pharmacologic Treatment for ADHD. Final Report. 2006.
Funding:
The funding source, the Center for Evidence-based Policy, is supported by 17 organizations, including 15 state Medicaid programs. These organizations selected the topic and had input into the Key Questions for this review. The content and conclusions of the review are entirely determined by the Evidence-based Practice Center researchers. The authors of this report have no financial interest in any company that makes or distributes the products reviewed in this report.
ADHD Drugs
Page 2 of 795
Final Report Update 1
Evidence Table 1. Placebo-controlled trials in preschool children and adolescents
Drug Effectiveness Review Project
Author Year (Quality) Preschool chidren Schleifer 1975 (Fair)
Study Design Setting
RCT DB crossover
Eligibility criteria
Preschool children diagnosed as hyperactive participated in this study
Comorbidity NR
Barkley 1988 (Fair)
RCT DB crossover
1. Parent and/or teacher complaints of short attention span, NR poor impulse control and restlessness 2. Age of onset of problem behavior prior to 6 years 3. A duration of problem behavior for at least 12 months 4. Scores on the Hyperactivity Index of the Conners Parent Rating Scale and the Werry-Weiss-Peters Activity Rating Scale greater than two SDs above the mean for same-age, same-sex normal children 5. Scores on the Home Situations Questionnaire indicating that the child posed behavior problems in at least eight of the 16 situations described on the questionnaire to establish pervasiveness of behavior problems 6. Absence of epilepsy, severe language delay, deafness, blindness, autism, psychosis or gross brain damage as estabished through developmental/medical histories and observation of the children
ADHD Drugs
Page 3 of 795
Final Report Update 1
Evidence Table 1. Placebo-controlled trials in preschool children and adolescents
Author Year (Quality) Preschool chidren Schleifer 1975 (Fair)
Interventions and total daily dose Duration Dosing schedule
methylphenidate: 2.5 mg - 20mg q.a.m and 10mg at lunch (mean dose = 5mg bid) Duration: 14-21 days
Run-in/Washout Period
NR/NR
Drug Effectiveness Review Project
Allowed other medications/ interventions NR
Barkley 1988
methylphenidate 0.15mg/kg bid or 0.5mg/kg bid
2 days/NR
NR
(Fair)
Duration: 7-10 days for each condition (baseline, placebo, low dose,
high dose)
Timing: NR
ADHD Drugs
Page 4 of 795
Final Report Update 1
Evidence Table 1. Placebo-controlled trials in preschool children and adolescents
Author Year (Quality) Preschool chidren Schleifer 1975 (Fair)
Method of Outcome Assessment and Timing of Assessment
Observation Hyperactivity Rating Scale
Timing: before and after the intervention
Age Gender Ethnicity
Mean age=4.08 years Gender: 89.3% male Ethnicity: NR
Barkley 1988 (Fair)
A free play (20 mins) and 5 task (20 mins total): mother-child Mean age=3.9 years
interactions were videotaped and separate coding of the
Gender: 70.3% male
interactions was done using the Response Class Matrix.
Ethnicity: NR
Timing: the last day of each drug condition
Drug Effectiveness Review Project
ADHD Drugs
Page 5 of 795
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- therapeutic class overview attention deficit hyperactivity disorder
- quick guide to adhd medication in québec september 2019 r
- adhd and sleep disorders m chadd
- ncaa banned drugs and medical exceptions policy guidelines regarding
- new dev ice may chadd
- drug class review on pharmacologic treatments for adhd ohsu
- adhd medication guide revised november 1 2019
- c practice guideline attention deficent hyperactivity disorder mhn
- new tool for adhd 2003 transcranial magnetic stimulation
- new approaches to studying medication treatment for children with adhd
Related searches
- new treatments for crps
- treatments for rsd in foot
- new treatments for crps 2018
- medication for adhd children
- schools for adhd near me
- alternative school for adhd children
- best schools for adhd children
- private schools for adhd kids
- medication for adhd adults
- treatments for blepharitis on eyelids
- medicine for adhd adults
- online school for adhd children